Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2007
11/22/2007WO2007084488A3 Adam10 and its uses related to infection
11/22/2007WO2007071777A3 Immuno-rna-constructs
11/22/2007WO2007071448A3 Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of muscle relaxation
11/22/2007WO2007060117A3 Chimeric keratin-binding effector proteins
11/22/2007WO2007042494A3 Microbiological production of 3-hydroxypropionic acid
11/22/2007WO2007035553A3 Methods and compositions for detecting neoplastic cells
11/22/2007WO2007019532A3 Peptide aptamers that bind to the rep proteins of ssdna viruses
11/22/2007WO2007019492A3 Methods for detection of a nucleic acid by sequential amplification
11/22/2007WO2007002762A3 Components of cell culture media produced from plant cells
11/22/2007WO2006128044A3 Compositions and methods for altering cellular functions
11/22/2007WO2006124375A3 Substances, compositions and methods for preventing and treating immune-mediated inflammatory disorders
11/22/2007WO2006091511A8 Primate t-lymphotropic viruses
11/22/2007WO2006084035A3 Transgenic chickens
11/22/2007WO2006044352A3 Canine cholecystokinin 1 receptor materials and their use
11/22/2007WO2005115479A3 Peptide conjugated, inosine-substituted antisense oligomer compound and method
11/22/2007WO2005100573A9 Fungal promoters for expressing a gene in a fungal cell
11/22/2007WO2005067478A3 Recombinant icosahedral virus like particle production in pseudomonads
11/22/2007WO2005035716A3 Nucleic acid molecules encoding novel human low-voltage activated calcium channel proteins, designated - alpha 1i-1 and alpha 1i-2, encoded proteins and methods of use thereof
11/22/2007WO2005012547A3 Multimeric oxidoreductases
11/22/2007WO2005001100A3 Plant fatty acid amide hydrolases
11/22/2007WO2004108894A3 Methods and compositions for amino acid production
11/22/2007WO2004104165A3 Ura5 gene and methods for stable genetic integration in yeast
11/22/2007WO2004099388A3 Cbl-b polypeptides, complexes and related methods
11/22/2007WO2003100074A3 Animal genotyping method
11/22/2007WO2003064601A3 Adult human olfactory stem cell
11/22/2007WO2003006672A3 Antimicrobial nucleic acid antibodies, and materials and methods for making and using same
11/22/2007WO2001040484A3 A novel polypeptide, a human atp-dependent serine protease 64 and the polynucleotide encoding the polypeptide
11/22/2007WO2000018212A8 Platelet-derived growth factor c, dna coding therefor, and uses thereof
11/22/2007US20070271635 Non-coding regulatory element polynucleotide molecules isolated from a nopaline synthase gene and vitopine synthase gene of Agrobacterium vitis are useful for expressing transgenes in plants
11/22/2007US20070271634 Preventing stress-induced apoptosis in plants
11/22/2007US20070271633 Expression vector comprising nucleotide sequences which confer disease, herbicide, heat, freeze, insect and drought resistance to plants
11/22/2007US20070271632 Delta 5 desaturase and its use in making polyunsaturated fatty acids
11/22/2007US20070271631 Method for the transformation of plant cell plastids
11/22/2007US20070271629 Artificial plant minichromosomes
11/22/2007US20070271628 Used for transformation efficiency, to stimulate plant cell growth, including stem cells, organogenesis, and somatic embryogenesis, and to induce apomixis; genetic engineering
11/22/2007US20070271627 Use of non-agrobacterium bacterial species for plant transformation
11/22/2007US20070271626 Soybean cultivar 435.TCS
11/22/2007US20070271625 Soybean cultivar 495.RC
11/22/2007US20070271624 Gene Encoding an Enzyme for Catalyzing Biosynthesis of Lignan, and Use Thereof
11/22/2007US20070271623 Plant Disease Resistance and Sar Regulator Protein
11/22/2007US20070271622 Soybean variety 0330739
11/22/2007US20070271621 Nucleic acids encoding a chimeric glycosyltransferase
11/22/2007US20070270582 A system capable of releasing a specific molecule by external stimulation such as oxidation and photoirradiation without impairing a target nucleic acid; useful in gene analysis and for therapy and diagnosis of various diseases
11/22/2007US20070270580 Methods of identifying synthetic transcriptional and translational regulatory elements, and compositions relating to same
11/22/2007US20070270578 Plants Having Increased Yield and a Method for Making the Same
11/22/2007US20070270575 Protein showing enhanced expression in cancer cells
11/22/2007US20070270574 Subtilisin variants
11/22/2007US20070270494 nucleic acid sequence encoding an acyl-CoA synthetase (ACoAS) that catalyzes the conversion of long chain PUFA free fatty acids (FFA) to acyl-CoA; transforming an organism to express PUFAs; improved methods of production of PUFAs
11/22/2007US20070270368 Compositions and methods for modulation of mcl-1 expression
11/22/2007US20070270365 Treatment of Eye Disorders Characterized by an Elevated Intraocular Pressure by siRNAs
11/22/2007US20070270363 Modulation of telomere length by oligonucleotides having a G-core sequence
11/22/2007US20070270360 Rna Interference Mediated Inhibition of Severe Acute Respiratory Syndrome (Sars) Gene Expression Using Short Interfering Nucleic Acid
11/22/2007US20070270343 Insulin-like growth factor polypeptide; for treating solid tumors having cells expressing IGFBP-3 receptors
11/22/2007US20070270334 Polypeptide-dimers for use in treatment and prevention of infection, bone, blood, eating, tumor, autoimmune and inflammatory disorders
11/22/2007US20070270329 Derived from human glioma cells exhibiting monocyte chemotactic activity at a concentration of 1 nM, and exhibiting an estimated molecular mass of 8,400 daltons.
11/22/2007US20070269892 FORMULATIONS FOR INTRACELLULAR DELIVERY dsRNA
11/22/2007US20070269891 Solid surface with immobilized degradable cationic polymer for transfecting eukaryotic cells
11/22/2007US20070269889 Stabilized siRNAs as transfection controls and silencing reagents
11/22/2007US20070269881 Carotene Synthase Gene and Uses Therefor
11/22/2007US20070269878 Compositions and methods for reverse transcription of nucleic acid molecules
11/22/2007US20070269869 culturing under conditions effective to produce lipids lacking pigmentation from microorganisms Thraustochytriales, genetically modified to selectively delete or inactivate a carotene synthase gene comprising a nucleic acid sequence codes a protein havng phytoene dehydrogenase, lycopene cyclase activity
11/22/2007US20070269865 Recombinant fragments of the human acetylcholine receptor and their use for treatment of myasthenia gravis
11/22/2007US20070269862 Installation of genomes or partial genomes into cells or cell-like systems
11/22/2007US20070269860 Modified Sarcosine Oxidases, Genes and Recombinant DNAs Thereof, and Methods for Preparing The Same
11/22/2007US20070269859 An isolated polynucleotide encoding a polypeptide having at least 90% sequence identity to SEQ ID NO:7 and having lecithin:cholesterolacyltransferase-like activity to alter sterol composition and oil production in plants and host cells; improved fatty acid, carotenoid, sterol and tocopherol; health
11/22/2007US20070269858 Combinatorial Biology
11/22/2007US20070269857 transfection of genetic vectors containing DNA that code proteins into prokaryotic host cells, culturing, allowing the cells to produce and accumulate isoprenoids, recovering isoprenoids consisting of ubiquinone, vitamin K2 and carotenoid
11/22/2007US20070269855 Recombinant polynucleotides encoding pro-geldanamycin producing polyketide synthases and accessory proteins, and uses thereof
11/22/2007US20070269847 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
11/22/2007US20070269838 Method for Whole Surrounding Surface Display of Target Proteins Using Bacterial Exoporium
11/22/2007US20070269812 System for detecting protease
11/22/2007US20070269811 Superoxide dismutase (SOD) gene and a method of identifying and cloning thereof
11/22/2007US20070269808 Wnt receptor compositions and methods
11/22/2007US20070269806 Polynucleotide Arrays
11/22/2007US20070269799 Nucleic acid amplification methods
11/22/2007US20070269504 Amphoteric liposomes
11/22/2007US20070269464 Epitope synchronization in antigen presenting cells
11/22/2007US20070269462 Novel exoenzyme toxin of Aeromonas salmonicida, and uses therefor
11/22/2007US20070269461 Recombinant Vaccine Against Japanese Encephalitis Virus (Jev) Infection and a Method Thereof
11/22/2007US20070269457 Immunotherapeutic compositions and methods
11/22/2007US20070269451 Nucleic Acid Vaccination
11/22/2007US20070269445 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a PRRSV and a method of detecting a PRRSV
11/22/2007US20070269435 Modified fusion protein comprising an anti-EGFR immunoglobulin moiety and a cytokine polypeptide moiety linked together
11/22/2007US20070269433 Cell cycle progressional proteins
11/22/2007US20070269424 Moraxella bovis cytotoxin, cytotoxin gene, antibodies and vaccines for prevention and treatment of moraxella bovis infections
11/22/2007US20070269419 Use of Caspase-8 Inhibitors for Modulating Hematopoiesis
11/22/2007US20070269414 Method for Producing Gene Transferred Denritic Cells
11/22/2007US20070269410 Chimeric adenoviral vectors
11/22/2007US20070269409 Adenoviral Vector Vaccine
11/22/2007US20070269408 GENES OF IL-12p40 SUBUNIT MUTATED FOR IMPROVING THE ACTIVITY OF IL-12 AND USE THEREOF FOR DNA VACCINE ADJUVANT
11/22/2007US20070269406 Transcatheter tumor immunoembolization
11/22/2007US20070269395 Inhibition of hairless protein mRNA
11/22/2007US20070269372 monoclonal antibodies or fragment thereof which binds a cell surface glycoprotein antigen located on the surface of human multiple myeloma tumor cells; for therapeutic, screening, diagnostic and cell purification purposes
11/22/2007US20070267301 Glucose Dehydrogenase/Cytochrome Fusion Protein
11/22/2007DE102006024113A1 Detecting a substance with anti-atherosclerotic property comprises incubating the first aliquot with a test substance, thrombocyte culturing medium and endothelial precursor cells and measuring invitro atherogenesis against control
11/22/2007CA2653231A1 Methods and compositions for obtaining marker-free transgenic plants
11/22/2007CA2652346A1 Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
11/22/2007CA2652304A1 Anti-inflammatory fusion protein
11/22/2007CA2652266A1 Modified vird2 protein and its use in improved gene transfer
11/22/2007CA2652094A1 High-affinity antagonists of elr-cxc chemokines